0512.HK · GRAND PHARMA
Hong Kong · RS rating 27 · As of 2026-10-14
| Price | 4.74 HKD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 51 / 36 / 26 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 14 / 12 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +46.1% |
| Market cap (USD) | $2.1B |